Tony Manning

Tony Manning PhD is an accomplished biotechnology professional with extensive experience in leadership roles across various organizations. As a current member of the Board of Directors at Monte Rosa Therapeutics and Palatin Technologies, Manning oversees the development of innovative biopharmaceuticals. Additionally, roles on the Scientific Advisory Boards of ProFound Therapeutics, BioHybrid Solutions, and 48Hour Discovery, along with the Advisory Committee at the Blavatnik Biomedical Accelerator at Harvard University, highlight Manning's influence in advancing medical innovations. As the Principal of Manning Bio Worldwide LLC, consultancy services are offered to biotech companies and academic institutions, further showcasing expertise in the field. Manning also served as Chief Scientific Officer at Momenta Pharmaceuticals and held senior vice president positions at Aileron Therapeutics, indicating a strong background in research and development. Manning holds a PhD in Biochemistry from the University of Otago.